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Abstract: Mathematical models to describe drug concentration profiles of topi-
cally administered drug in the anterior chamber aqueous humor have been proposed
by several authors. The aim of this paper is to present a mathematical model to
predict the drug concentration in the anterior chamber when a therapeutical contact
lens with the drug is entrapped in nanoparticles is used.
Keywords: Ophthalmic contact lens, nanoparticles, polymeric matrix, cornea, an-
terior chamber, diffusion.
1. Introduction
Diseases of the anterior segment of the eye are mostly treated by topical
ocular administration in the inferior fornix of the conjunctiva. Nevertheless
the procedure is extremely inefficient because when a drop (50 to 100휇ℓ per
drop) is instilled in the eye, the ophthalmic drug has a short residence time in
the conjunctival sac, less than 5 minutes, and only 1−5% of the applied drug
penetrates the cornea reaching the intraocular tissues. The biovailability
tends to be low and depends on the precorneal fluids dynamics, drug binding
to tear proteins, conjunctival drug absorption, tears turn over, resistance
to corneal penetration, nasolachrymal drainage, metabolic degradation and
non-productive absorption. The absorption and the efficacy of the instilled
drug can be increased by altering its formulation and/or by changing the
local conditions.
In the last years many researchers have proposed the use of therapeutic
contact lenses to increase the ocular bioavailability of ophthalmic drugs. The
first attempt to increase the residence time of the ophthalmic drug was the
use of soaked contact lenses. The lens is hydrated once placed on to the
cornea and releases the drug until an equilibrium is reached between drug
concentration in the contact lens and in the conjunctival sac; the maximum
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drug loading is limited by the solubility of the drug in the polymeric matrix
and the delivery period of time is still very short.
Several approaches have been considered to overcome the limitations of
soaked contact lenses: lenses where the ophthalmic drug is linked with the
polymeric matrix ([7], [8], [12], [13]) and contact lenses where the drug is
encapsulated in nanoparticles dispersed in the matrix ([3], [5], [6], [10]). The
nanoparticles are formed by polymerization, during or after which the drug
is added, leading to covalent drug binding to the polymer. This binding of
the drug depends on its physicochemical properties as well as the nature of
the polymer; experimental and mathematical predictions on drug delivery
were provided([4]). Recently delivery system based on PLGA nanoparticles
incorporating drug have been proposed in [11].
However, from a medical point of view, the central question is to have
a prediction of the drug concentration in the anterior chamber of the eye.
In this case, mathematical models are the only available tool to make such
prediction. The mathematical models describing the behaviour of drug con-
centration across the cornea when a drop is instilled were proposed in [2], [14]
and [15]. Nevertheless, when the drug is delivered from a contact lens the
concentration and mass profiles across the cornea are qualitatively different.
The main contribution of this paper is to present a mathematical model to
predict drug concentration in the anterior chamber when the drug is delivered
from a therapeutical contact lens where the drug is dispersed in the polymeric
matrix and encapsulated in nanoparticles. A particular case of our model is
drug delivery from soaked lenses. The model presented in this paper takes
into account the essential mechanisms occurring in the delivery system. Drug
lost due to tear drainage is not considered. This assumption is based on the
observation that there is limited mixing between the fluid in the post tear
film and the outside tear fluid ( [10]). Moreover we do not take into account
the drug lost by the conjunctiva. A more detailed model where drug lost by
the conjunctiva is considered and the cornea is decomposed in epithelium,
stroma and endothelium, can be developed along the same lines.
The paper is organized as follows. In Section 2 we introduce the mathe-
matical model composed by coupled diffusion partial differential equations
linked with flux conditions at the boundaries. The drug concentration in
the anterior chamber is obtained using Laplace transforms in Section 3. In
Section 4 we present several plots obtained from the theoretical solutions and
we compare our results with the concentration plots in the anterior chamber
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in the case of topical drug administration. In Section 5 the we compare nu-
merically the drug concentration in the anterior chamber when a drop and
an ophthalmic contact lens are used in drug administration. In Section 6
some conclusions are established.
2. The mathematical model
We consider a compartmental model to represent a contact lens, the cornea
and the anterior chamber of the eye(Figure 1). We assume that the drug is
dispersed in the contact lens and entrapped in particles as described in [3].
Figure 1. Schematic diagram of the drug transport from a ther-
apeutical contact lens.
In this model the cornea is represented by only one compartment because
this assumption simplifies the establishment of a closed formula for the drug
concentration in the anterior chamber. We note that if the components
of the cornea tissue were considered - epithelium, Bowman’s layer, stroma,
Descemet’s membrane and endothelium - the procedure could be generalized
in a straightforward way. In Figure 2 we represent schematically a contact
lens with nanoparticles.
The main physical mechanisms underlying the drug transport from the
therapeutical contact lens to the anterior chamber are the diffusion, me-
tabolism and binding. The drug release from the therapeutical lens can be
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Figure 2. Schematic diagram of the lens with nanoparticles
filled with drug.
described by the system of partial differential equations⎧⎨
⎩
∂퐶푔
∂푡
= 퐷푔
∂2퐶푔
∂푥2
−
∂퐶푏
∂푡
, 푥 ∈ (−ℓ1, 0), 푡 > 0,
∂퐶푏
∂푡
= 휆(퐶푏 − 퐶푔), 푥 ∈ (−ℓ1, 0), 푡 > 0,
(1)
where 퐶푔 represents the drug concentration in the gel, 퐶푏 the drug concen-
tration in the nanoparticles, 퐷푔 the diffusion coefficient of the drug in the
gel and 휆 is defined by
휆 = −
푆
푉
퐾,
where 푆 and 푉 represent respectively the surface and the volume of the
nanoparticles and 퐾 the mass transfer coefficient for drug transport across
the particle surface.
The behavior of the drug concentration in the cornea, 퐶푐, is described by
∂퐶푐
∂푡
= 퐷푐
∂2퐶푐
∂푥2
−퐾푐퐶
푐, 푥 ∈ (0, ℓ2), 푡 > 0, (2)
where 퐷푐 stands for the diffusion coefficient in the cornea and 퐾푐 represents
a coefficient that takes into account the metabolic consumption.
The conservation of drug in the anterior chamber is described by ([14])
푑퐶푎
푑푡
=
1
푉푎
(
−퐷푐푓푐퐴푐
∂퐶푐
∂푥
(ℓ2, 푡)− 퐶푙푎퐶
푎(푡)
)
, (3)
where 퐴푐 is the surface area of the cornea, 푓푐 represents the fraction of 퐴푐
occupied by the diffusional route considered and 푉푎 is the distribution volume
of solute in the anterior chamber.
Equations (1), (2) and (3) are coupled with the initial conditions
퐶푔(푥, 0) = 퐶0푔, 퐶푏(푥, 0) = 퐶0푏, 푥 ∈ [−ℓ1, 0], (4)
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퐶푐(푥, 0) = 0, 푥 ∈ [0, ℓ1], (5)
퐶푎(0) = 0, (6)
and the boundary conditions
∂퐶푔
∂푥
(−ℓ1, 푡) = 0, 푡 > 0, (7)
퐷푔푓푔퐴푔
∂퐶푔
∂푥
(0, 푡) = 퐷푐푓푐퐴푐
∂퐶푐
∂푥
(0, 푡), 푡 > 0, (8)
퐶푔(0, 푡) = 퐾푔,푐퐶
푐(0, 푡), 푡 > 0, (9)
−퐷푐푓푐퐴푐
∂퐶푐
∂푥
(ℓ2, 푡) = 퐾푐,푎
(
퐶푐(ℓ2, 푡)− 퐶
푎(푡)
)
, 푡 > 0. (10)
In (8) 푓푔 represents the fraction of the lens surface 퐴푔 that is occupied by the
diffusional route. The constants 퐾푔,푐 (9) and 퐾푐,푎 (10) represent respectively
the quotient of the distribution coefficient in the lens and the cornea (퐾푔,푐)
and in the cornea and the anterior chamber (퐾푐,푎).
3. Drug concentration in the anterior chamber
Equations (1)-(3) coupled with initial conditions (4)-(6) and boundary con-
ditions (7)-(10) are solved using Laplace transforms.
Let us represent by 푋 the Laplace transform of 푋. From (1), (4) we have⎧⎨
⎩
−퐶0푔 + 푝퐶푔 = 퐷
∂2퐶푔
∂푥2
+ 퐶0푏 − 푝퐶푏
−퐶0푏 + 푝퐶푏 = 휆(퐶푔 − 퐶푏).
(11)
Computing 퐶푏 from the second equation in (11) and replacing in the first
one we obtain
퐷
∂2퐶푔
∂푥2
−
푝(푝+ 2휆)
푝+ 휆
퐶푔 = −퐶0푔 − 퐶0푏
휆
푝+ 휆
,
which has the general solution
퐶푔(푥, 푝) = 퐹1푒
훼1푥 + 퐹2푒
−훼1푥 +
(푝+ 휆)퐶0푔 + 휆퐶0푏
푝(푝+ 2휆)
, (12)
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where 퐹1, 퐹2 are constants to be computed and 훼1 is defined by
훼1 =
√
푝(푝+ 2휆)
퐷푔(푝+ 휆)
. (13)
From (2) and (5) we obtain for 퐶푐(푥, 푝) the following expression
퐶푐(푥, 푝) = 퐵1푒
훼2푥 +퐵2푒
−훼2푥, (14)
where 퐵1, 퐵2 are constants to be computed and 훼2 is defined by
훼2 =
√
푝 +퐾푐
퐷푐
. (15)
From (3) and (6) we get
(푝+
퐶푙푎
푉푎
)퐶푎(푝) = −
퐷푐푓푐퐴푐
푉푎
∂퐶푐
∂푥
(ℓ2, 푝). (16)
As from (10) we have
−퐷푐푓푐퐴푐
∂퐶푐
∂푥
(ℓ2, 푝) = 퐾푐,푎
(
퐶푐(ℓ2, 푝)− 퐶푎(푝)
)
, (17)
we conclude from (16)
퐶푎(푝) =
퐾푐,푎
푉푎푝+ 퐶푙푎 +퐾푐,푎
(
퐵1푒
훼2ℓ2 +퐵2푒
−훼2ℓ2
)
. (18)
We establish in what follows a linear system for the coefficients 퐹1, 퐹2, 퐵1, 퐵2 :
As from (7) we have
∂퐶푔
∂푥
(−ℓ1, 푝) = 0
we obtain from (12)
퐹1푒
−훼1ℓ1 − 퐹2푒
훼1ℓ1 = 0. (19)
Analogously, as from (9) we have
퐶푔(0, 푝) = 퐾푔,푐퐶푐(0, 푝),
we obtain from (12) and (14)
퐹1 + 퐹2 −퐾푔,푐(퐵1 + 퐵2) = −
(푝+ 휆)퐶0푔 + 휆퐶0푏
푝(푝+ 2휆)
. (20)
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Condition (8) implies that
퐷푔푓푔퐴푔
∂퐶푔
∂푥
(0, 푝) = 퐷푐푓푐퐴푐
∂퐶푐
∂푥
(0, 푝)
which combined with (12) and (14) allow us to obtain
퐷푔푓푔퐴푔훼1
(
퐹1 − 퐹2
)
−퐷푐푓푐퐴푐훼2
(
퐵1 −퐵2) = 0. (21)
Finally from (14), (17) and (18) we establish
−푅1푒
훼2ℓ2퐵1 +푅2푒
−훼2ℓ2퐵2 = 0, (22)
where
푅1 = 퐷푐푓푐퐴푐훼2 +퐾푐,푎
푉푎푝 + 퐶푙푎
푉푎푝+ 퐶푙푎 +퐾푐,푎
and
푅2 = 퐷푐푓푐퐴푐훼2 −퐾푐,푎
푉푎푝+ 퐶푙푎
푉푎푝+ 퐶푙푎 +퐾푐,푎
.
Solving linear system (19)-(22) and replacing in (18) the parameters 퐵1 and
퐵2 we obtain
퐶푎(푝) =
1
푔(푝)
(
퐾푐,푎
√
퐷푔퐷푐퐴푔퐴푐푓푔푓푐
√
(푝+ 푘푐)
(
(푝+ 휆)퐶0푔 + 휆퐶0푏
))
, (23)
where
푔(푝) = 푝(푝+ 2휆)퐾푔,푐
√
퐷푔퐴푔푓푔푆1(푝)
+
√
푝(푝+ 휆)(푝+ 2휆)(푝+퐾푐)
√
퐷푐퐴푐푓푐 coth(훼1ℓ1)푆2(푝)
and
푆1(푝) = 퐴푐푓푐
√
퐷푐
√
푝+퐾푐 cosh(훼2ℓ2)(푉푎푝+ 퐶퐿푎 +퐾푐,푎)
+퐾푐,푎 sinh(훼2ℓ2)(푉푎푝 + 퐶푙푎),
푆2(푝) = 퐴푐푓푐
√
퐷푐
√
푝+퐾푐 sinh(훼2ℓ2)(푉푎푝+ 퐶푙푎 +퐾푐,푎)
+퐾푐,푎 cosh(훼2ℓ2)(푉푎푝 + 퐶푙푎)
and 훼1, 훼2 are defined respectively by (13) and (15).
To prove the existence of 퐶푎(푡) it is sufficient to point out that
lim
푝→+∞
퐶푎(푝) = 0
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and
lim
푝→+∞
푝퐶푎(푝) = 0
hold.
4. Simulation of the drug concentration in the anterior
chamber
Following [1] we compute from (23) an approximation for 퐶푎(푡) defined by
퐶푎(푡) ≃
1
푇
푒훾푡
(1
2
퐶푎(훾) +
∞∑
푛=1
푅푒
(
퐶푎(훾 +
푖푛휋
푇
)푒
푖푛휋푡
푇
))
, (24)
for 푡 ∈ (0, 2푇 ), where 훾 = 훼−
푙푛(퐸푟)
2푇
and with 훼 representing a constant
larger than
max{푅푒(푃 ) : 푃 is a pole of퐶푎(푠)}
and 퐸푟 is a tolerance error.
In the simulations presented we consider a therapeutical lens loaded with
nanoparticles studied in [3] characterized by the parameters presented in
Table 1.
Symbol Definition (unities) Numerical value
퐶0푔 initial drug concentration in the hydrogel (푔/푐푚3) 0.28× 10−3
퐶0푏 initial drug concentration in the nanoparticles (푔/푐푚3) 0.05102× 10−3
ℓ1 lens thickness (푚푚) 0.8
퐷푔 diffusion coefficient of the drug in the hydrogel (푐푚
2/푚푖푛) 2× 10−6
휆 transfer coefficient 2× 10−4
Table 1: Parameters characterizing the therapeutical lens loaded with nanoparticles ([3]).
The parameters characterizing the anatomical and physiological human eye were consid-
ered in [2], [14] and they are presented in Table 2.
Symbol Definition (unities) Numerical value
퐾푐,푎 quotient of the distribution coefficient in the cornea 10
퐾푐 metabolic consumption drug coefficient in the cornea 1.0713× 10
−5
ℓ2 cornea thickness (푚푚) 0.5
푉푎 distribution volume of solute in the anterior chamber (휇푙) 150− 3000
퐶푙푎 clearence in the anterior chamber (휇푙/푚푖푛) 1− 30
퐷푐 diffusion coefficient in the cornea (푐푚
2/푠) 5.74× 10−6
퐴푐 surface area of the cornea 0.9
푓푐 fraction of the cornea surface occupied by the diffusional route 1
Table 2: Parameters characterizing the anatomical and physiological human eye ([2],
[14]).
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The values of 퐷푐 and 퐾푐 presented in Table 2 are an average of the corresponding values
in the epithelium, stroma and endothelium for a lipophilic drug. In the simulations we
considered 퐴푔 = 1( surface area of the lens) 퐾푔,푐 = 1( quotient of the distribution coefficient
in the lens and the cornea) and 푓푔 = 0.75 ( fraction of the lens surface occupied by the
diffusional route).
In what concerns the numerical approximation for the Laplace inverse 퐶푎(푡) we took
퐸푟 = 10
−6, 훼 = 0.001, 푇 = 104.
In Figure 3 we plot the drug concentration in the anterior chamber for different values
of the distribution volume of solute. An increase of such volume implies a decrease of the
maximum drug concentration. However for large times the drug concentration appears as
an increasing function of 푉푎. A possible explanation for this fact is given by equation (10).
In fact the lower is 퐶푎, the higher is the flux from the cornea, which can justify the large
time behaviour of the model.
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1
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2
2.5
x 10−6
Time (min)
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(g/
cm
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V
a
=3000
V
a
=1000
V
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=600
Figure 3. Dug concentration in the anterior chamber, 퐶푎, for
different values of the distribution volume of solute.
The dependence of 퐶푎 on the diffusion coefficient of the drug in the contact lens is illus-
trated in Figure 4. As the drug diffusion in the lens increases, an increasing of the drug
concentration in the anterior chamber is observed.
An increasing of the drug clearance in the anterior chamber produces a decreasing of the
drug concentration in this compartment. This behavior is illustrated in Figure 5
The influence of the fraction of the lens surface occupied by the diffusional route on the
behavior of the drug concentration in the anterior chamber is illustrated in Figure 6. As this
factor increases an increasing of the dug concentration in the anterior chamber is observed.
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Figure 4. Drug concentration in the anterior chamber 퐶푎 for
different values of the diffusion coefficient in the lens.
5. Topical administration versus ophthalmic lens
In what follows we compare numerically the drug concentration in the anterior chamber
when a drop and a ophthalmic lens are used in drug administration. As previously mentioned
we did not considered the cornea divided in epithelium, stroma and endothelium. The same
assumption is considered in the mathematical model for topical administrations introduced
in [14] and considered later in [2]. Using the previous assumption the evolution of a drug in
the anterior chamber is defined by
푑퐶푓
푑푡
=
퐷푐푓푐퐴푐
∂퐶푐
∂푥
(0, 푡)− 푆퐶푓
푉퐻 + 푉푖푒−퐾푑푡
, (25)
where 퐶푓 denotes the drug concentration in the tear film and 푆 represents the (fixed) lacrimal
secretion rate. In (25) 푘푑 denotes the drainage constant, 푉퐿 and 푉푖 represent the normal
lacrimal volume and the initial tear volume after an instillation of drug. The previous
equation is coupled with the differential equations (2), (3), initial conditions (5), (6),
퐶푓(0) = 퐶
0
푓 , (26)
and with the boundary condition (10). The coupling between the drug evolution in the tear
film and in the cornea is defined by
−퐷푐푓푐퐴푐
∂퐶푐
∂푥
(0, 푡) = 퐾푐,푎
(
퐶푓(푡)− 퐶
푐(0, 푡)). (27)
In Figure 7 we plot the time evolution of drug concentration in the anterior chamber when
a drop (퐶푎푑푟표푝) and a lens (퐶
푎
푙푒푛푠) are used in drug administration. In the computation of
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Figure 5. Drug concentration in the anterior chamber 퐶푎 for
different values of the clearance in the anterior chamber.
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Figure 6. Drug concentration in the anterior chamber 퐶푎 for
different values of the of the lens surface occupied by the diffu-
sional route.
퐶푎푑푟표푝(푡) the following parameters
푘푑 = 1.45(푚푖푛
−1), 퐶0푓 = 0.5× 10
−3푔/푐푚3, 푉퐿 = 7휇퐿, 푉푖 = 10휇푙, 푆 = 1.2휇푙/푚푖푛
are used.
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Figure 7. Evolution of the drug concentration in the anterior
chamber when a drop (퐶푎푑푟표푝) and a lenses (퐶
푎
푙푒푛푠) are used in the
eye drug administration.
From Figure 7 we conclude that the use of contact lens leads to a higher concentration of
the drug in the anterior chamber during a larger period of time than topical administrations.
We observe that after the first hour of the application of the eye drop the maximum concen-
tration is reached in the anterior chamber. After this time the drug concentration decreases
rapidly approaching zero after five hours. This behavior is not observed when we use the
polymeric lens. In fact in this case after five hours the drug concentration is larger than
half of the maximum of the drug concentration reached by eye drops. Moreover, after eight
hours the drug concentration in the anterior chamber is nearly one quarter of the maximum
attained when a drop is used.
6. Conclusions
Several authors proposed the use of ophthalmic contact lenses to replace the traditional
topically administration ([5], [6], [10]). The evolution in time of the drug concentration in
the anterior chamber is crucial for the treatment of the majority of diseases of the ante-
rior segment of the eye. Mathematical models are the only tools available to predict such
evolution.
In this paper a mathematical model to predict the behaviour of drug mass and concentra-
tion in the anterior chamber is proposed. Drug is delivery from dispersed and encapsulated
nanoparticles on a therapeutical contact lens. The theoretical expression for the drug con-
centration in the anterior chamber was obtained which can be used to study the qualitative
properties of the model.
The evolution in time of the drug concentration in the anterior chamber 퐶푎 and its
dependence on several parameters of the model were simulated. Such evolution was also
numerically compared with the drug concentration in the anterior chamber when a eye drop
is used. For the contact lens, highest values of 퐶푎 were observed during a larger time period.
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We remark that topical delivery eye drops leads to a short residence time of the drug because
most part of the applied drug is lost due to tear drainage.
If a lens is used as an ophthalmic drug delivery system then the released drug remains
entrapped in the interface tear film between the contact lens and the cornea ([10]). This
fact leads to an increase of the drug residence time. Moreover the total amount of drug
contained in the ophthalmic lens with nanoparticles is greater than the corresponding value
for an eye drop.
References
[1] J. Ahn, S. Kang, Y.H. Kwon, A flexible inverse Laplace transform algorithm and its applica-
tion, Computing, 2003, 71, 115-131.
[2] R. Avtar, D. Tandon, Modeling the drug transport in the anterior segment of the eye, European
Journal of Pharmaceutical Sciences, 2008, 35, 175-182.
[3] J.A. Ferreira, P. Oliveira, P.M. Silva, A. Carreira, H. Gil, J.N. Murta, Sustained drug re-
leased from contact lenses,Pre´-Publicac¸a˜o 09-20, Departamento de Matema´tica, Universidade
de Coimbra, Submitted.
[4] J.V. Forrester, A.D. Dick, P. McMenamin, W. Lee, The Eye. Basic sciences in practice. 3rd
ed, Saunders, Elsevier, 2008.
[5] D. Gulsen, A. Chauhan, Ophthalmic drug delivery from contact lenses, Investegative Oph-
thalmology and Visual Science, 2004, 45, 2342-2347.
[6] D. Gulsen, A. Chauhan, Dispersion of microemulsion drops in HEMA hydrogel: a potential
ophthalmic drug delivery vehicle, International Journal of Pharmaceutics, 2005, 292, 95-117.
[7] H. Hiratani, A. Fujiwara, Y. Tamya, Y. Mizutani, A. Alvarez-Lorenzo, Ocular release of timilol
from molecular imprinted contact lense, 2005, Biomaterials, 26, 1293-1298.
[8] Y. Kapoor, J.C. Thomas, G. Tan, V.T. John, A. Chauhan, Surfactant-laden soft contact lenses
for extended delivery of ophthalmic drugs, 2009, Biomaterials, 30, 867-878.
[9] J. Kim, A. Conway, A. Chauhan, Extended delivery of ophthalmic drugs by silicone hydorgel
contact lenses, Biomaterials, 2008, 29, 2259-2269.
[10] C.C. Li, A. Chauhan, Modeling ophthalmic drug delivery by soaked contact lenses, Industrial
and Engineering Chemistry Research, 2006, 45, 3718-3734.
[11] E. Vega, F. Gamisans, M.L. Grac´ıa, A. Chauvet, F. Lacoulonche, M.E. Egea, PLGA nanosh-
eres for the ocular delivery of flurbiprofen: drug release and interactions, Journal of Pharma-
ceutical Sciences, 2008, 97, 5306-5317.
[12] S. Venkatesh, S.P. Sizemore, M.E. Byrne, Biomimetric hydrogels for enhanced loading and
extended release of ocular therapeutic, Biomaterials, 2007, 28, 717-724.
[13] L. Xinming, C. Yingde, A.W. Lloyd, S.V. Mikhalovky, S.R. Sandeman, C.A. Howel, L. Liewen,
Polymeric hydrogels for novel contact lens-based ophthalmic drug delivery system: a review,
Contactlens & Anterior Eye, 2008, 31, 57-64.
[14] W. Zhang, M.R. Prausnitz, A. Edwards, Model for transient drug diffusion across cornea,
Journal of Controlled Release, 2004, 99, 241-258.
[15] N. Worakula, J.R. Robinson, Ocular pharmacokinetics/pharmacodynamics, European Journal
of Pharmaceutics and Biopharmaceutics, 1997, 44, 71-83.
J.A. Ferreira
CMUC,Department of Mathematics, University of Coimbra, Apartado 3008, 3001-454
Coimbra, Portugal
14 J.A. FERREIRA, P. DE OLIVEIRA, P. M. DA SILVA AND J.N. MURTA
E-mail address : ferreira@mat.uc.pt
URL: http://www.mat.uc.pt/˜ferreira
P. de Oliveira
CMUC,Department of Mathematics, University of Coimbra, Apartado 3008, 3001-454
Coimbra, Portugal
E-mail address : poliveirt@mat.uc.pt
P. M. da Silva
Department of Physics and Mathematics, ISEC, Rua Pedro Nunes, Quinta da Nora, 3030-
199 Coimbra, Portugal
E-mail address : pascals@isec.pt
J.N. Murta
Department of Ophthalmology, Faculty of Medicine, University of Coimbra, 301-454
Coimbra, Portugal
